While Novo Nordisk won FDA approval in 2019 for Rybelsus, an oral semaglutide formulation from Novo Nordisk
Stick to a gentle skincare routine, be sure to moisturise, drink plenty of water to stay hydrated, eat healthily, manage stress levels and go makeup-free when you can
These interventions are not cosmetic tools, but targeted strategies designed to modulate underlying physiologic systems
Ferritin: structure, biosynthesis, and role in iron metabolism
Which weight-management trials to read For weight specifically, the STEP program studied semaglutide and the SURMOUNT program studied tirzepatide
A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
